Trial intelligence / Profile preview

Olanzapine and Amisulpride Combination in Schizophrenia (COMBINE)

NCT01609153Phase 4Completed

Sponsor
Heinrich Heine University Düsseldorf
Start
Jun 2012
Primary completion
Apr 2019
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of olanzapine, amisulpride in schizophrenia, schizoaffective disorder, sponsored by Heinrich Heine University Düsseldorf. Started Jun 2012; status: completed.

02

Drugs

olanzapineamisulpride
03

Conditions

schizophreniaschizoaffective disorder

Beyond the preview

Go deeper on NCT01609153.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01609153.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call